yankeeviv

我心匪石,不可轉也。我心匪席,不可卷也。
正文

胖子2015年10月22在Englewood Hospital腸癌切除手術前的各種血檢結果和數據

(2016-03-07 13:18:05) 下一個

1. Oct 14, 2015. 12 Lead ECG

Ventricular Rate 95 BPM
Atrial Rate 95 BPM
P-R Interval 166 ms
QRS Duration 78 ms
Q-T Interval 372 ms
QTC Calculation(Bezet) 467 ms
P Axis 92 degrees
R Axis -16 degrees
T Axis 30 degrees
Diagnois Line Sinus rhythm with occasional Premature ventricular complexes
Diagnois Line Inferior myocardial infarction , age undetermined
Diagnois Line ST & T wave abnormality, consider lateral ischemia
Diagnois Line Abnormal ECG
Diagnois Line No previous ECGs available
http://MUSEPROD/musescripts/museweb.dll?RetrieveTestByDateTime?PatientID=010153577&Date=14-10-2015&Time=13%3a24%3a38%3a255&TestType=ECG&Site=1&OutputType=PDF&Ext=PDF
 
 
2. Oct 14, 2015. CA19-9.  20099W
Analyte Value Flag Reference Status
CA 19-9  27 U/ML     Final
CA 19-9       Final
Notes: Reference range: <34
SEE COMMENT
This test was performed using the Siemens chemiluminescent
method. Values obtained from different assay methods
cannot be used interchangeably. CA 19-9 levels, regardless
of value, should not be interpreted as absolute evidence of
the presence or absence of disease.

Test Performed at:
Quest Diagnostics
One Malcolm Avenue
Teterboro, NJ 07608
Lawrence Tsao, M.D.
 
3. Oct 14, 2015 CEA
Analyte Value Flag Reference Status
CEA 4.2 NG/ML H <3.0 Final
 
4. Oct 14, 2015. TOTAL LDH
 
Analyte Value Flag Reference Status
TOTAL LDH 590 U/L   313-618 Final
 
5. Oct 14, 2015. HBA1C W EAG
Analyte Value Flag Reference Status
EST. AVG. GLUCOSE 169 MG/DL     Final
HEMOGLOBIN A1C 7.5 % H <6.5 Final
HEMOGLOBIN A1C       Final
Notes: 
ADA RECOMMENDATIONS:
DIAGNOSIS: 5.7-6.4% PREDIABETIC
=OR>6.5% TYPE 2 DIABETIC
DIABETIC CONTROL: <7.0% PROPERLY MANAGED

GLYCOHEMOGLOBIN ASSAYS SHOULD BE PERFORMED AT LEAST TWICE YEARLY FOR THE
PATIENT WHO HAS STABLE GLYCEMIC CONTROL.

6. Oct 14, 2015 FERRITIN

Analyte Value Flag Reference Status
FERRITIN 354.0 NG/ML   17.9-464 Final
 
7. Oct 14, 2015 MISYS EHMC
 
Analyte Value Flag Reference Status
ALBUMIN 4.0 G/DL   3.5-5.0 Final
ALK PHOS 87 U/L   38-126 Final
ALT 28 U/L   21-72 Final
ANION GAP W/ K 15 MMOL/L   9-18 Final
AST 22 U/L   17-59 Final
BILIRUBIN,TOTAL 0.6 MG/DL   0.2-1.3 Final
BUN 25 MG/DL H 9-20 Final
CALCIUM 9.0 MG/DL   8.4-10.2 Final
CHLORIDE 102 MMOL/L   98-107 Final
CO2 25 MMOL/L   22-30 Final
CREATININE 1.4 MG/DL H 0.7-1.3 Final
GFR, EST. BY MDRD 52.0 ML/MIN/1.73M SQ L >60 Final
GLUCOSE 230 MG/DL H 74-106 Final
GLUCOSE       Final
Notes: (AMERICAN DIABETES ASSOCIATION RECOMMENDATION)
FASTING GLUCOSE
<100 NORMAL
100-125 PREDIABETIC
126 OR HIGHER DIABETIC
 
POTASSIUM 4.4 MMOL/L   3.5-5.1 Final
SODIUM 138 MMOL/L   137-145 Final
TOTAL PROTEIN 6.9 G/DL   6.3-8.2 Final
GFR COMMENT       Final
Notes: IF PATIENT IS OF AFRICAN DESCENT, MULTIPLY ESTIMATED GFR BY 1.21.
 
 
 
8.Oct 14, 2015 TYPE & SCREEN (XM CONVERTIBLE)
Analyte Value Flag Reference Status
TYPE & SCREEN (XM CONVERTIBLE)       Final
Notes: CROSSMATCH EXPIRATION:10/22/2015
 
TYPE & SCREEN (XM CONVERTIBLE)       Final
Notes: ABO/RH(D):O NEGATIVE
ANTIBODY SCREEN:NEGATIVE
 
TYPE & SCREEN (XM CONVERTIBLE)       Final
Notes: BLOOD COMPONENT TYPE:RED CELLS
 
TYPE & SCREEN (XM CONVERTIBLE) UNITS ORDERED:0      Final
 
9. Oct 14, 2015 IRON PANEL
Analyte Value Flag Reference Status
TSI 18 %   15-50 Final
IRON 46 UG/DL L 49-181 Final
TIBC 261 UG/DL

 

10. Oct 14, 2015 PTPTT

Analyte Value Flag Reference Status
INR 1.0   0.9-1.1 Final
INR       Final
Notes: *LEVEL OF THERAPY*
2.0-3.0 DEEP VEIN THROMBOSIS, PULMONARY EMBOLISM,
ATRIAL FIBRILLATION, PREVENTION OF
SYST.EMBOLI IN VALVULAR HEART DISEASE,
ACUTE MYOCARDIAL INFARCTION.
2.5-3.5 PREVENTION OF SYSTEMIC EMBOLISM
WITH MECHANICAL HEART VALVES.
3.0-4.0 ANTIPHOSPHOLIPID ANTIBODY SYNDROME.
3.0-4.5 PREVENTION OF SYSTEMIC EMBOLISM IN
HIGH RISK PATIENTS WITH MECHANICAL
MITRAL OR AORTIC VALVES,
RECURRENT SYSTEMIC EMBOLISM.
 
PT 13.1 SECS   11.8-14.8 Final
PT       Final
Notes: PLEASE NOTE NEW REFERENCE RANGE
 
PTT 33 SECS   24-38 Final
Provider Comments: This result has been automatically released to your health record at the direction of your provider. Your provider may not have yet reviewed this result.
 
11. Oct 14, 2015  DIFFERENTIAL
Analyte Value Flag Reference Status
BASO 0.2 %   0.0-1.5 Final
BASO ABSOLUTE 0.0 K/UL   0.0-0.2 Final
DIFF TYPE       Final
Notes: AUTOMATED DIFF
 
EO 0.9 %   0.1-4.5 Final
EO ABSOLUTE 0.1 K/UL   0.0-0.5 Final
LYMPH 8.3 % L 19.4-45.4 Final
LYMPH ABSOLUTE 0.7 K/UL L 1.2-3.4 Final
MONO 5.9 %   1.6-11.3 Final
MONO ABSOLUTE 0.5 K/UL   0.0-0.8 Final
NEUTRO 84.7 % H 44.1-69.7 Final
NEUTRO ABSOLUTE 7.3 K/UL   1.8-7.7 Final
Provider Comments: This result has been automatically released to your health record at the direction of your provider. Your provider may not have yet reviewed this result.
 
12. Oct 14, 2015 CBC WITH DIFF BATTERY
Analyte Value Flag Reference Status
HCT 32.8 % L 35.0-47.0 Final
HGB 11.4 G/DL L 13.5-18.0 Final
MCH 31.1 PG   26.0-34.0 Final
MCHC 34.8 G/DL   32.0-36.0 Final
MCV 89.3 FL   81.8-97.8 Final
PLT 213 K/UL   140.0-400.0 Final
RBC 3.67 M/UL L 4.00-5.70 Final
RDW 13.7 %   10.0-15.2 Final
WBC 8.6 K/UL   4.5-11.0 Final
Provider Comments: This result has been automatically released to your health record at the direction of your provider. Your provider may not have yet reviewed this result
[ 打印 ]
閱讀 ()評論 (2)
評論
quanquan1125 回複 悄悄話 hug
lilyzyl 回複 悄悄話 Hug
登錄後才可評論.